XML 71 R46.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurement (Tables)
12 Months Ended
Dec. 31, 2022
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table displays our assets and liabilities measured on our consolidated balance sheets at fair value on a recurring basis as of December 31, 2022 and 2021.
Table 16.1: Assets and Liabilities Measured at Fair Value on a Recurring Basis
December 31, 2022
Fair Value Measurements Using
Netting Adjustments(1)
(Dollars in millions)Level 1Level 2Level 3Total
Assets:
Securities available for sale:
U.S. Treasury securities$5,041 $0 $0 — $5,041 
RMBS0 62,353 236 — 62,589 
CMBS0 7,728 142 — 7,870 
Other securities186 1,233 0 — 1,419 
Total securities available for sale5,227 71,314 378 — 76,919 
Loans held for sale0 191 0 — 191 
Other assets:
Derivative assets(2)
474 2,545 79 $(1,134)1,964 
Other(3)
464 3 36 — 503 
Total assets$6,165 $74,053 $493 $(1,134)$79,577 
Liabilities:
Other liabilities:
Derivative liabilities(2)
$823 $3,653 $74 $(1,235)$3,315 
Total liabilities$823 $3,653 $74 $(1,235)$3,315 
December 31, 2021
Fair Value Measurements Using
Netting Adjustments(1)
(Dollars in millions)Level 1Level 2Level 3Total
Assets:
Securities available for sale:
U.S. Treasury securities$9,442 $$— $9,442 
RMBS73,358 258 — 73,616 
CMBS9,360 — 9,369 
Other securities206 2,628 — 2,834 
Total securities available for sale9,648 85,346 267 — 95,261 
Loans held for sale1,026 — 1,026 
Other assets:
Derivative assets(2)
406 2,200 84 $(542)2,148 
Other(3)
526 41 — 573 
Total assets$10,580 $88,578 $392 $(542)$99,008 
Liabilities:
Other liabilities:
Derivative liabilities(2)
$838 $965 $65 $(544)$1,324 
Total liabilities$838 $965 $65 $(544)$1,324 
__________
(1)Represents balance sheet netting of derivative assets and liabilities, and related payables and receivables for cash collateral held or placed with the same counterparty. See “Note 9—Derivative Instruments and Hedging Activities” for additional information.
(2)Does not reflect $4 million and $11 million recognized as a net valuation allowance on derivative assets and liabilities for non-performance risk as of December 31, 2022 and 2021, respectively. Non-performance risk is included in the measurement of derivative assets and liabilities on our consolidated balance sheets, and is recorded through non-interest income in the consolidated statements of income.
(3)As of December 31, 2022 and 2021, other includes retained interests in securitizations of $36 million and $41 million, deferred compensation plan assets of $453 million and $490 million, and equity securities of $14 million (including unrealized losses of $23 million) and $42 million (including unrealized losses of $36 million), respectively.
Schedule of Level 3 Inputs Reconciliation
The table below presents a reconciliation for all assets and liabilities measured and recognized at fair value on a recurring basis using significant unobservable inputs (Level 3) for the years ended December 31, 2022, 2021 and 2020. Generally, transfers into Level 3 were primarily driven by the usage of unobservable assumptions in the pricing of these financial instruments as evidenced by wider pricing variations among pricing vendors and transfers out of Level 3 were primarily driven by the usage of assumptions corroborated by market observable information as evidenced by tighter pricing among multiple pricing sources.
Table 16.2: Level 3 Recurring Fair Value Rollforward
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Year Ended December 31, 2022
Total Gains (Losses)
(Realized/Unrealized)
Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of December 31, 2022(1)
(Dollars in millions)Balance, January 1, 2022
Included
in Net
Income(1)
Included in OCIPurchasesSalesIssuancesSettlementsTransfers
Into
Level 3
Transfers
Out of
Level 3
Balance, December 31, 2022
Securities available for sale:(2)
RMBS$258 $18 $(32)$0 $0 $0 $(60)$123 $(71)$236 $10 
CMBS(1)(3)0 0 0 (15)190 (38)142 (1)
Total securities available for sale267 17 (35)0 0 0 (75)313 (109)378 9 
Other assets:
Retained interests in securitizations41 (5)0 0 0 0 0 0 0 36 (5)
Net derivative assets (liabilities)(3)
19 (65)0 0 0 36 3 (28)40 5 (33)
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Year Ended December 31, 2021
Total Gains (Losses)
(Realized/Unrealized)
Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of December 31, 2021(1)
(Dollars in millions)Balance, January 1, 2021
Included
in Net
Income(1)
Included in OCIPurchasesSalesIssuancesSettlementsTransfers
Into
Level 3
Transfers
Out of
Level 3
Balance, December 31, 2021
Securities available for sale:(2)
RMBS$328 $18 $$$$$(91)$106 $(108)$258 $15 
CMBS111 (2)(7)(93)
Total securities available for sale439 18 (98)106 (201)267 15 
Other assets:
Retained interests in securitizations55 (14)41 (14)
Net derivative assets (liabilities)(3)
31 (43)68 (37)(6)19 (20)
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
Year Ended December 31, 2020
Total Gains (Losses)
(Realized/Unrealized)
Net Unrealized Gains (Losses) Included in Net Income Related to Assets and Liabilities Still Held as of December 31, 2020(1)
(Dollars in millions)Balance, January 1, 2020
Included
in Net
Income(1)
Included in OCIPurchasesSalesIssuancesSettlementsTransfers
Into
Level 3
Transfers
Out of
Level 3
Balance, December 31, 2020
Securities available for sale:(2)(4)
RMBS$433 $22 $(19)$$$$(72)$206 $(242)$328 $16 
CMBS13 (3)(9)(32)371 (229)111 
Total securities available for sale446 19 (28)(104)577 (471)439 16 
Other assets:
Retained interests in securitizations66 (11)55 (11)
Net derivative assets (liabilities)(3)
26 10 43 (37)(11)31 10 
_________
(1)Realized gains (losses) on securities available for sale are included in net securities gains (losses) and retained interests in securitizations are reported as a component of non-interest income in our consolidated statements of income. Gains (losses) on derivatives are included as a component of net interest income or non-interest income in our consolidated statements of income.
(2)Net unrealized losses included in other comprehensive income related to Level 3 securities available for sale still held as of December 31, 2022 were $57 million. Net unrealized losses included in other comprehensive income related to Level 3 securities available for sale still held as of December 31, 2021 were $4 million. Net unrealized losses included in other comprehensive income related to Level 3 securities available for sale still held as of December 31, 2020 were $21 million.
(3)Includes derivative assets and liabilities of $79 million and $74 million, respectively, as of December 31, 2022 and $84 million and $65 million, respectively, as of December 31, 2021, and $141 million and $110 million, respectively, as of December 31, 2020.
(4)The fair value of RMBS as of January 1, 2020 includes a cumulative adjustment of $4 million from the adoption of the CECL standard.
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis Quantitative Information The following table presents the significant unobservable inputs used to determine the fair values of our Level 3 financial instruments on a recurring basis. We utilize multiple vendor pricing services to obtain fair value for our securities. Several of our vendor pricing services are only able to provide unobservable input information for a limited number of securities due to software licensing restrictions. Other vendor pricing services are able to provide unobservable input information for all securities for which they provide a valuation. As a result, the unobservable input information for the securities available for sale presented below represents a composite summary of all information we are able to obtain. The unobservable input information for all other Level 3 financial instruments is based on the assumptions used in our internal valuation models.
Table 16.3: Quantitative Information about Level 3 Fair Value Measurements
Quantitative Information about Level 3 Fair Value Measurements
(Dollars in millions)Fair Value at
December 31,
2022
Significant
Valuation
Techniques
Significant
Unobservable
Inputs
Range
Weighted
Average(1)
Securities available for sale:
RMBS$236 Discounted cash flows (vendor pricing)Yield
Voluntary prepayment rate
Default rate
Loss severity
3-12%
4-20%
0-11%
30-80%
7%
8%
2%
58%
CMBS142 Discounted cash flows (vendor pricing)Yield
4-5%
5%
Other assets:
Retained interests in securitizations(2)
36 Discounted cash flowsLife of receivables (months)
Voluntary prepayment rate
Discount rate
Default rate
Loss severity
30-43
9-18%
4-7%
1%
62-291%
N/A
Net derivative assets (liabilities)5 Discounted cash flowsSwap rates
3-4%
4%
Quantitative Information about Level 3 Fair Value Measurements
(Dollars in millions)Fair Value at
December 31,
2021
Significant
Valuation
Techniques
Significant
Unobservable
Inputs
Range
Weighted
Average(1)
Securities available for sale:
RMBS$258 Discounted cash flows (vendor pricing)Yield
Voluntary prepayment rate
Default rate
Loss severity
0-21%
5-40%
1-11%
30-100%
3%
11%
2%
65%
CMBSDiscounted cash flows (vendor pricing)Yield
1-2%
1%
Other assets:
Retained interests in securitizations(2)
41 Discounted cash flowsLife of receivables (months)
Voluntary prepayment rate
Discount rate
Default rate
Loss severity
29-36
9-18%
2-8%
3-4%
72-151%
N/A
Net derivative assets (liabilities)19 Discounted cash flowsSwap rates
1-2%
2%
__________
(1)Weighted averages are calculated by using the product of the input multiplied by the relative fair value of the instruments.
(2)Due to the nature of the various mortgage securitization structures in which we have retained interests, it is not meaningful to present a consolidated weighted average for the significant unobservable inputs.
Schedule of Assets Measured at Fair Value on Nonrecurring Basis
The following table presents the carrying value of the assets measured at fair value on a nonrecurring basis and still held as of December 31, 2022 and 2021, and for which a nonrecurring fair value measurement was recorded during the year then ended.
Table 16.4: Nonrecurring Fair Value Measurements
December 31, 2022
Estimated Fair Value HierarchyTotal
(Dollars in millions)Level 2Level 3
Loans held for investment$0 $284 $284 
Loans held for sale11 0 11 
Other assets(1)
0 220 220 
Total$11 $504 $515 
December 31, 2021
Estimated Fair Value HierarchyTotal
(Dollars in millions)Level 2Level 3
Loans held for investment$$194 $194 
Loans held for sale118 118 
Other assets(1)
325 325 
Total$118 $519 $637 
__________
(1)As of December 31, 2022, other assets included investments accounted for under measurement alternative of $4 million, cost method investments of $3 million, repossessed assets of $55 million and long-lived assets held for sale and right-of-use assets totaling $158 million. As of December 31, 2021, other assets included equity method investments of $50 million, investments accounted for under measurement alternative of $29 million, repossessed assets of $40 million and long-lived assets held for sale and right-of-use assets totaling $206 million.
Schedule of Earnings Related to Assets Measured at Fair Value on Nonrecurring Basis
The following table presents total nonrecurring fair value measurements for the period, included in earnings, attributable to the change in fair value relating to assets that are still held at December 31, 2022 and 2021.
Table 16.5: Nonrecurring Fair Value Measurements Included in Earnings
Total Gains (Losses)
Year Ended December 31,
(Dollars in millions)20222021
Loans held for investment$30 $
Other assets(1)
(38)(72)
Total$(8)$(70)
__________
(1)Other assets include fair value adjustments related to repossessed assets, long-lived assets held for sale and right-of-use assets, and equity investments accounted for under the measurement alternative.
Schedule of Fair Value of Financial Instruments
The following table presents the carrying value and estimated fair value, including the level within the fair value hierarchy, of our financial instruments that are not measured at fair value on a recurring basis on our consolidated balance sheets as of December 31, 2022 and 2021.
Table 16.6: Fair Value of Financial Instruments
December 31, 2022
Carrying
Value
Estimated
Fair Value
Estimated Fair Value Hierarchy
(Dollars in millions)Level 1Level 2Level 3
Financial assets:
Cash and cash equivalents$30,856 $30,856 $5,193 $25,663 $0 
Restricted cash for securitization investors400 400 400 0 0 
Net loans held for investment299,091 302,920 0 0 302,920 
Loans held for sale11 11 0 11 0 
Interest receivable2,104 2,104 0 2,104 0 
Other investments(1)
1,326 1,326 0 1,326 0 
Financial liabilities:
Deposits with defined maturities45,858 45,531 0 45,531 0 
Securitized debt obligations16,973 16,918 0 16,918 0 
Senior and subordinated notes30,826 30,744 0 30,744 0 
Federal funds purchased and securities loaned or sold under agreements to repurchase883 883 0 883 0 
Interest payable527 527 0 527 0 
 December 31, 2021
Carrying
Value
Estimated
Fair Value
Estimated Fair Value Hierarchy
(Dollars in millions)Level 1Level 2Level 3
Financial assets:
Cash and cash equivalents$21,746 $21,746 $4,164 $17,582 $
Restricted cash for securitization investors308 308 308 
Net loans held for investment265,910 270,508 270,508 
Loans held for sale4,862 5,091 5,091 
Interest receivable1,460 1,460 1,460 
Other investments(1)
1,344 1,344 1,344 
Financial liabilities:
Deposits with defined maturities17,923 18,062 18,062 
Securitized debt obligations14,994 15,122 15,122 
Senior and subordinated notes27,219 27,842 27,842 
Federal funds purchased and securities loaned or sold under agreements to repurchase820 820 820 
Interest payable281 281 281 
__________
(1)Other investments include FHLB and Federal Reserve stock. These investments are included in other assets on our consolidated balance sheets.